INTRODUCTION
Steroid hormones regulate multiple processes during development and adult life. In Drosophila, the steroid hormone 20-hydroxyecdysone (20E) triggers the transcriptional changes required for gonad development, larval molting, as well as the onset and completion of metamorphosis (Sliter & Gilbert 1992; Henrich et al. 1993; Carney & Bender 2000; Riddiford et al. 2000; Beckstead et al. 2005) . Differentiation of imaginal structures and neuronal remodeling, two major features of metamorphosis, have been used as cellular systems to analyze the functional role of proteins that elicit morphogenetic changes at this phase of the life cycle (Schubiger et al. 2005; Brown et al. 2006; Santos et al. 2006). 20E regulates gene expression by binding to its nuclear receptor, EcR (King-Jones & Thummel 2005) . To bind 20E and stimulate transcription, however, EcR must heterodimerize with Ultraspiracle (USP) to reconstitute specific activation domains (Yao et al. 1992) . Different 20E levels activate transcription of different sets of genes (Champlin & Truman 1998; Li & White 2003; Schubiger et al. 2003) . Like its vertebrate cognates (Chen & Evans 1995) , unliganded EcR and USP act as repressors of transcription, whereas the liganded receptor stimulates expression of target genes (Tsai et al. 1999; Ghbeish et al. 2001; Schubiger et al. 2003) .
Based on sequence identities, it is considered that the mammalian orthologs of EcR are the group H of nuclear receptor subfamily 1 that include LXR and FXR, while USP is represented by the Retinoic X Receptor (RXR) (Robyr et al. 2000; Fitzgerald et al. 2002) . The regulated activity of these receptors has a widespread effect on multiple aspects of development. For example, in mammals, they regulate cholesterol, osteoclast differentiation, triglyceride metabolism, and their impaired function leads to cardiovascular, bone, metabolic and, possibly, Alzheimer's diseases (Patel & Forman 2004; Beaven & Tontonoz 2006; Mark et al. 2006 ; Robertson et al. 2006; Xiong et al. 2008; Spyridon et al. 2011) .
The EcR gene of Drosophila produces three protein isoforms (EcRA, EcRB1 and EcRB2) by using two promoters and alternative splicing (Talbot et al. 1993 ). The three isoforms are able to heterodimerize USP and share the same carboxy terminus, which includes the hormone binding and DNA binding domains, while the amino termini are unique to each isoform. The three EcR isoforms are hypothesized to play specific functions based on their distinct, temporal and spatial expression patterns and the distinct biochemical properties of their specific amino terminal domains (Kim et al. 1999; Sung & Robinow 2000; Davis et al. 2005) .
Mutational analyses of the EcR gene support the proposed EcR isoform functional specificity.
Mutants that fully inactivate EcR are lethal in embryogenesis while, in isoform specific alleles, lethality occurs at characteristic stages of development. For instance, isoform B1 mutants fail to pupate while the majority of EcRA mutants die later during metamorphosis (Carney et al. 2004; Davis et al. 2005) . Development is also halted by an excess of EcR function, with virtually the same phenotypes as the loss-of-function alleles (Schubiger et al. 2003) , suggesting that EcR levels must be kept tightly regulated for normal development. The A and B1 isoforms are expressed in complementary patterns, with one notable exception; the prothoracic gland, which exhibits expression of both isoforms (Talbot et al. 1993) . The other nuclear receptor, USP, is expressed ubiquitously and it exhibits a DNA binding motif that is required for repression, but dispensable for activation, of metamorphosis (Schubiger & Truman 2000; Ghbeish et al. 2001; Erezyilmaz et al. 2006) . The mechanisms that lead to the activation of a specific receptor or, more often, a receptor isoform are still poorly known for ecdysone and most other steroid hormones across species. Thus, identifying a mechanism for the specific activation of a receptor isoform would be of general interest in the field of steroid hormone signaling due to the conserved nature of the proteins involved in this study.
Ubiquitin-proteasome degradation is one of the major processes to regulate protein levels and function (Bedford et al. 2010) . Increasing evidence supports a key role of ubiquitylation and proteasome dependent proteolysis in gene transcription (Collins & Tansey 2006) . Activity of the 26S proteasome is required for proper transcription of genes encoding the glucocorticoid and many other steroid hormone receptors (Dennis et al. 2005; Kinyamu & Archer 2007) . The ubiquitin pathway includes the activity of at least three different enzymes, a ubiquitin activating enzyme or E1, a ubiquitin conjugating enzyme or E2, and a ligase enzyme or E3. The specificity of the pathway is determined mainly by the E3 ligase, and, consequently, in mammals there is a large number of E3 (>100) compared to the 25 E2 or the single E1 (Glickman & Ciechanover 2002) . Two families of E3 ligases are known so far, the HECT (homologous to E6-AP C-terminus) and the RING finger. Drosophila Ariadne-1a (ARI-1a) belongs to the latter and it is the founder member of a subfamily containing the RBR string motif (RING Finger, In Between RING Fingers, RING Finger) (Aguilera et al. 2000) . Indeed, most RBR proteins function as E3 enzymes (Lorick et al. 1999; Joazeiro & Weissman 2000; Kamura et al. 2002; Marin & Ferrus 2002; Marin et al. 2004; Capili et al. 2004 ). The gene ari-1a is expressed throughout development, but its lack of function (Aguilera et al. 2000) or its generalized over-expression result in lethality at the end of the third larval instar, indicating a quantitatively regulated requirement for this ubiquitin ligase activity in metamorphosis. Here we investigated the in vivo targets of ARI-1a, a conserved E3 enzyme, and the corresponding cellular effects, to explain its role in metamorphosis. We have previously described UbcD10 as a novel ubiquitin conjugating enzyme (E2) that interacts with ARI-1a (Aguilera et al. 2000) . Now, we identify EcRA as a bona fide substrate of ARI1a, since it is regulated in response to ARI-1a levels and it is ubiquitylated in vitro by ARI-1a with the concourse of UbcD10. In addition, ARI-1a interacts with USP and contributes to the transcriptional activity of the EcRA/USP complex.
EXPERIMENTAL PROCEDURES
Fly strains, genetic interaction and target gene expression studies. The mutant allele ari1a 2 was described previously (Aguilera et al. 2000) . 
(expressed in an ari-1a domain) and phm-Gal4UAS-CD8-GFP (expressed in the phantom domain, the prothoracic cells of the ring gland). The expression domains of Gal4 drivers were tested using the reporters UAS-LacZ or UAS-GFP S65T . For gene interaction studies, ari1a 2 /FM7i females were crossed with spn1 (serine protease inhibitor 1), eIF2b (translation initiation factor), Bonus (nuclear receptor cofactor), EcRA, EcRA-B1-B2, EcRB1-B2 and transcription factors Ftz-f1, Eip78C, Eip75B and Eip55E mutant males. The percentage of viability was obtained as the number of ari-1a 2 ; */+ males rescued from lethality divided by the number of sibling adults of the most viable genotype in each cross. Lethal phases were determined as previously described (Aguilera et al. 2000) .
For the generation of pUAS-ari-1a line, the ari-1a open reading frame (ORF) was cloned into the pUASt vector. To generate the myc tagged ARI-1a construct (pUAS-myc-ari-1a), the ari1a ORF was first cloned into the plasmid pCMA vector containing 6x myc in N-terminal. The myc-ari-1a chimera was subcloned into pUASt. Germ line transformations were performed in y w embryos following standard procedures . The expression of selected genes was severely attenuated by using the corresponding interference RNA (RNAi) (Dietzl et al. 2007) (Kawasaki et al. 2005) . In all cases, protein extracts were resolved by SDS-PAGE and blots were incubated with antibodies against ARI-1a; EcRA (15G1a) (Hybridoma Bank) at a 1:100 dilution; EcRB1 (AD4.4) (Hybridoma Bank) at 1:500 dilution; anti-nucleoporin p62 antibody at 1:1000 (BD Bioscience) overnight at 4ºC followed by the secondary HRP-conjugated antibodies (SIGMA) at 1:5000. The signal was detected by autoradiography using Supersignal west Pico substrate (Pierce). When required, blots were quantified by densitometry using the Quantity-1 software (BioRad), normalizing values to Actin content.
In vitro ubiquitylation assay: cDNAs for the E2 conjugating enzyme UbcD10, ari1a and
EcRA were cloned in frame with Poly Histidine tag in the vector pRSET (Invitrogen).
Proteins were purified using His Gravitrap columns (GE Healthcare) following manufacturer's instructions. Previously, KRX bacteria (Promega) containing the plasmids were induced with IPTG and rhamnose for 16 h at 30ºC and then lysated and homogenized by sonication. For the ubiquitylation assays, the E1 enzyme (Boston Biochem), the affinity purified UbcD10, ARI-1a and EcRA were incubated with or without ubiquitin (Boston Biochem) or, in other type of approach, E1, UbCd10 and EcRA were incubated in the presence of HA-ubiquitin (Boston Biochem) with or without affinity purified ARI-1a. In both cases the reaction was incubated at 30ºC for 2 h in ubiquitylation buffer (50 mM Tris-HCl, pH 7.5, 2.5 mM MgCl 2 , 1mM ATP, and 0.5 mM dithiothreitol) and then stopped by adding Laemli buffer. The samples were then resolved by SDS-PAGE.
Cell culture and cell transfection assays: Schneider line 2 and L57-3-11 (EcR deficient line) (Cherbas & Cherbas 1997 ) cells were grown as described (Cherbas et al. 1994) . All collected from wild type LIII larvae, RNA extraction and RT were carried out as described previously, for the PCR, Taqman MGB probes specific for ECRA or ECRB1/B2 or Ari 1a
were used, but instead of running the reaction in the real time PCR system, reactions were carried out in a standard PCR (MJ Research) and run in an agarose gel.
RESULTS
Changes in ARI-1a levels lead to phenotypes similar to ecdysone pathway genes deregulation.
Since we had previously described the ari-1a loss-of-function mutant phenotypes (Aguilera et al. 2000) , we addressed here the over-expression counterpart in order to explore possible trait similarities. Phenotypes caused by the excess of ARI-1a function were investigated using the UAS/Gal4 system (Brand & Perrimon 1993) . Generalized over-expression by the tubulinGal4-LL7 driver causes lethality mostly at the white pre-pupae stage (Fig. 1A) . These mutants degenerate in their pupal cases and never emerge as adults. Using Gal4 drivers with more restricted expression domains (how-Gal4-24B) (see Supplementary Table S1 ), individuals develop further but arrest before head eversion and leg elongation, resulting in a cryptocephalic-like phenotype (Fig. 1B,C) . In general, these traits are quite similar to those of genes involved in the ecdysone signaling pathway (Bender et al. 1997; D'Avino & Thummel 2000; Schubiger et al. 2003; Fortier et al. 2003; Beckstead et al. 2005; King-Jones & Thummel 2005; Davis et al. 2005) . Interestingly, the Gal4 driver NP1063 that corresponds to some regulatory sequences of the endogenous ari-1a gene does not cause lethality (not shown). This driver, however, is expressed in the fat body and salivary glands at the late LIII and pre-pupae stages becoming general (Malpighian tubuli, nervous system, muscles, etc.) at the late pupae stage and throughout adulthood. This observation indicates that the ARI-1a over-expression becomes deleterious at a critical time window around the onset of metamorphosis. This indication prompted our in depth study of the putative relationship between ARI-1a and ecdysone pathway genes.
EcR isoforms are differentially expressed in larval versus imaginal tissues, with isoform A being predominant in imaginal structures, the wing disc in particular, (Talbot et al. 1993; Cherbas et al. 2003; Davis et al. 2005) . We found that wing discs are sensitive to the over-expression of ARI-1a. All tested Gal4 drivers for wing disc regions lead to abnormal morphology of the adult wing when ARI-1a is in excess, although each domain of expression yielded characteristic morphological abnormalities (Fig.1D-J and Supplementary Fig. S1 ).
Also, we explored the effect of over-expressing ARI-1a or down-expressing EcRA using the Beadex-Gal4-MS1096 and in both cases abnormal wing morphology of the same type was observed ( Fig. 1I-K) . The joint effect of over-expressing ARI-1a and down-expressing EcRA, resulted in an enhanced wing phenotype (Supplementary Fig. S1 ). In agreement with the lack of expression of EcRB1 isoform in the imaginal discs, silencing EcRB1 by means of an RNAi construct in the Dpp-Gal4 domain yielded normal wings (not shown).
In most insects, ecdysone biosynthesis occurs in the cells of the prothoracic gland during larval and pupal stages (Gilbert & Warren 2005) . These cells are particularly interesting in the context of this study because they express all EcR isoforms (Talbot et al. 1993) . We manipulated the expression of ARI-1a, EcR or USP in the prothoracic gland using phm-Gal4, which drives expression specifically in the gland. The expression of RNAi against usp or EcR genes results in lethality demonstrating the requirement of the EcR/USP complex in this gland (Fig 1L) . The over-or down-expression of ARI-1a causes a reduction of adult viability of about 50%, and the same effect is observed with the over-expression of EcRA.
Interestingly, the joint over-expression of ARI-1a and EcRA rescued the lethality that the over-expression of each protein separately causes (Fig 1L) . Taken together, the data so far suggest a possible functional relationship between ARI-1a and ecdysone related proteins, particularly EcRA, justifying further experiments to identify the actual molecular mechanisms.
ARI-1a translocates to the nucleus, binds EcRA, and functionally interacts with ecdysone signaling genes.
Since EcR and its partner, USP, are nuclear receptors and the previous set of data suggested a possible functional interaction EcR-ARI-1a, we analyzed the cellular localization of ARI-1a. Its sequence exhibits a nuclear localization motif, KKWIKK, although cell fractionation experiments from whole body adults had indicated a cytoplasmic, rather than nuclear, localization (Aguilera et al. 2000) . To determine if ARI-1a could translocate to the nucleus S2 cells were transfected with a GFP-tagged or a myc-tagged ARI-1a constructs. Colocalization of tagged ARI-1a and DAPI can be observed after immunostaining ( Fig. 2A-F) .
For a further assessment, we checked the cellular localization of endogenous ARI-1a in S2 cells using an ARI-1a specific antibody and DAPI for nuclear identification ( Fig. 2G-I ). ARI1a appears co-localized to a large extent with the DAPI nuclear signal. In most cells, the tag signal can be detected in the cytoplasm as well as in the nucleus. Finally, a direct cell fractionation assay on S2 cells transfected with myc-tagged ARI-1a clearly shows that the signal can be present in the nucleus as well as in the cytoplasm ( Figure 2J ). These observations indicate that ARI-1a, either endogenous or transfected, can locate to the nucleus, as reported for EcR and USP (Gwozdz et al. 2007 ) (see Discussion).
Yeast-two-hybrid assays were used to check if the putative interactions were direct.
Out of the five candidate proteins tested, only EcRA and USP gave a positive result (Fig.   2K ). The choice of the five candidates was based on their reported role in ecdysonedependent responses during metamorphosis and the results of the genetic interaction assay (see below and Fig. 3A) . It is important to note that EcR isoform B1 gave a negative result in this assay suggesting that the interaction between ARI-1a and EcR could be isoform specific.
As a validation of the yeast-two-hybrid interaction, co-immunoprecipitation (CoIP) assays were carried out between EcRA and ARI-1a. To that end, myc-tagged ari-1a UAS construct transformant fly lines were established. The functionality of the myc-ARI-1a chimera was tested by reproducing the pre-pupal lethal phenotypes described above under ARI-1a overexpression using the tub-Gal4-LL7 driver. These white pre-pupae were used for protein extractions, CoIP and Western blots. The data demonstrate that EcRA and ARI-1a interact in a cellular context (Fig. 2L) . The equivalent attempt with USP failed because of the available USP-antibody was ineffective in Western blots. As an alternative, we generated a Flag-tagged USP construct with which we co-transfected L57-3-11 cells. Here, the anti-Flag antibody did not recognize any product Co-IP with ARI-1a-myc. Thus, the YTH interaction detected between ARI-1a and USP could not be validated in this assay. This negative result could indicate a false positive in the YTH assay or the existence of an inhibitory factor in that particular cell line. Since equivalent assays in a HEK cell line also failed to yield a positive result (not shown) we concluded that the YTH result between ARI-1a and USP is likely a false positive. Nevertheless, as shown below, ARI-1a does regulate the protein levels of USP and, hence, there must be a functional interaction between these two proteins.
Further, we aimed to determine the specificity and structural bases that sustain the interaction between ARI-1a and EcRA. To that end we used L57-3-11 line cells cotransfected with the corresponding constructs. The data show no evidence of interaction with USP ( Fig. 2M) . By contrast, EcRA, but not EcRB1, co-IP with ARI-1a (Fig. 2N) . Since all EcR isoforms share the same C-terminus, the AF2 fragment, we included in the same Co-IP experiment a Flag-tagged AF2 fragment. The result, however, was negative pointing to the differential N-terminus, the AF1 fragment as a potential site for the interaction. However, a further set of Co-IP experiments with a Flag-tagged AF1 fragment yielded also negative results (Fig. 2O) . Taken together these structural data, we concluded that the ARI-1a/EcRA interaction is a bona fide feature of the biology of the cell, but the fully normal sequences of both proteins are required. Also, the interaction specificity among the EcR isoforms is not dependent on the differential N-termini (AF1 fragment), probably because it requires a 3D feature that only the entire protein can exhibit. Indeed, E3 enzymes frequently use these high order structural motifs to recognize their susbstratum (Qian et al. 2009 ) .
Beyond these structural considerations, we searched for genetic evidences of the ARI- because its Cys150>Tyr change in the N-terminus RING finger motif causes fully penetrant lethality (Aguilera et al. 2000) .
Seven out of ten genes tested, showed evidence of functional interaction by producing a number of ari-1a 2 survivors (Fig. 3A) . The most effective suppression was detected with EcR mutants, in particular with those of isoform A. In general, rescued males did not appear healthy and survived only for about five days in which they seldom moved or fed. This result provides an in vivo evidence for the interaction between ARI-1a and EcRA. Further, since the rescued genotypes still contain one normal copy of the tested gene, it suggests that the functional relationship between ARI-1a and these ecdysone related genes relies on their relative stoichiometry rather than on a switch type process. Additional genetic interaction tests were carried out with USP, the known partner of EcR. We found that their corresponding lethal phases changed as a function of the relative contents of these two proteins (Fig. 3B) . In a background of excess of ARI-1a, lethality occurs at the pupal stage. However, if the endogenous ari-1a and usp genes are inactivated by means of null mutant alleles, lethality occurs at progressively earlier stages. In the most extreme case studied, the null condition for USP and the generalized over expression of ARI-1a, development is stopped at mid embryogenesis (for specific genotypes, see legend in Figure 3 ).
Transcription of ecdysone signaling genes is modified by ARI-1a.
We performed microarray analyses from mutant and over-expressing ARI-1a genotypes in order to investigate if the interaction of ARI-1a with ecdysone signaling genes, translates into significant changes in transcription. The transcriptome data (Supplementary   Tables S2-3 and Supplementary Figure S2) were filtered by two criteria: 1) genes that change their expression in the experimental genotypes but not between the two corresponding sibling control genotypes, and 2) genes that change their expression in one direction in the ari-1a lack-of-function and in the opposite direction in the ari-1a excess-of-function genotypes.
Gene ontology of the genes that are up-regulated in the mutant and, at the same time, down-regulated in the over-expressing larvae and vice versa, was analyzed using GOEAST isoforms) and USP. In general, they showed either up-or down-regulation depending on the status of ari-1a expression levels (Fig 4) . Thus, we concluded that ARI-1a elicits transcriptional changes in a dose dependent manner over a set of genes that include several of the 20E signaling pathway.
In vivo effects of ARI-1a at the single cell level.
To visualize in single cells the phenotypes caused by modifying ARI-1a levels we choose the Malpighian tubuli cells because of their relative large size and accessibility. The C649 Gal4 driver is expressed in the stellate cells of this tissue (Sozen et al. 1997) . First, we carried out RT-PCR assays to check if the partners under study were present in this tissue.
The data show that ari-1a, EcRA and EcRB1/2 genes are expressed (Fig. 5A) . In the driven expression experiments, we found that the over-expression of ARI-1a always leads to an increment in the fluorescent signal of the GFP-tagged membrane protein CD8 used as a reporter (Fig. 5B,C,H) . This effect correlates with the loss of endoplasmic reticulum in ari-1a
lack-of-function mutant that we reported previously in photoreceptor cells (Aguilera et al. 2000) . Thus, both phenotypes are consistent with the level of ARI-1a expression. To test if this phenomenon could be due to the regulation of EcRA specifically, we used an UAS-RNAi to down-regulate EcRA. The resulting phenotype on cell membranes is very similar to that produced by the excess of ARI-1a (Fig. 5D,E,H) . As in the previous experiments, this effect is also EcR isoform specific, as the reduction on EcRB1 levels had no effect on the CD8-GFP signal (Fig. 5F,G,H) . The same phenotypes were reproduced using two other membrane reporters which are specific for the endoplasmic reticulum, the proteins Rtnl1 and Pdi (data not shown). These phenotypes are consistent with the high requirement of membranogenesis during metamorphosis, the developmental stage where the loss or the excess of ari-1a function causes lethality.
Taken together, the data so far indicate that ARI-1a regulates metamorphosis, most likely as a result of its direct interaction with the nuclear transcriptional receptor EcRA and, perhaps indirectly, with its heterodimeric partner USP. The mechanism of this regulation, however, could be executed at the protein or the gene transcription levels. Thus, we set out to analyze these two alternatives.
ARI-1a regulates the protein levels of EcRA and USP in vivo and it ubiquitylates EcRA in vitro
Since ARI-1a is an E3 enzyme, we addressed the effects on the putative substrates. We measured protein levels of EcRA and USP under lack-and excess-of-function conditions for ARI-1a. Similar experiments were carried out for the EcRB1, in order to define the specificity of ARI-1a activity. Pre-pupae of ari-1a 2 and tub-Gal4-LL7>UAS-ari-1a lethal mutants were used for protein extracts and Western blotting with EcRA, EcRB1 and USP specific antibodies. Quantitative differences for EcRA, and to a lesser extent for USP, were clearly detected (Fig. 6A, B) . While EcRB1 showed no apparent change, EcRA levels decreased four fold when ARI-1a was over-expressed, and increased six fold in ari-1a lack-of-function mutants. By contrast; USP levels changed in the opposite direction to those of EcRA; they doubled in the first case, and decreased two fold in the second.
Further, since the EcRA levels changed in concert with those of ARI-1a and the two proteins directly bind to each other, we tested the putative ubiquitylation of EcRA by ARI-1a.
In the in vitro assay used to that end, we included the E2 enzyme previously identified as a direct interactor with ARI-1a, UbcD10. In the presence of ubiquitin and the enzymes E1, UbcD10 and ARI-1a, at least two high molecular weight bands were detected, that corresponded to ubiquitylated EcRA as shown by the anti-EcRA specific antibody. Under the same conditions, but in the absence of ubiquitin, EcRA remained unmodified (Fig 6C) . In order to test the dependence of this ubiquitylation on the presence of the E3 enzyme, we carried out an additional test under the presence or absence of ARI-1a (Fig 6D) . In this latter experiment we used a HA-tagged ubiquitin to improve ubiquitin detection.
Interpreting the full set of data, we conclude that ARI-1a regulates the EcRA/USP protein levels via ubiquitylation of EcRA and, indirectly, the RNA levels of both genes, perhaps through a feed-back loop of the proteins over the transcription of their encoding genes. This interpretation is akin to the case of the vertebrates estrogen receptor , ER, where the two processes, ubiquitin/proteasome degradation of the protein and transcriptional activation of the gene are independent and mediated through distinct structural motifs (Tateishi et al. 2004; Valley et al. 2005) .
DISCUSSION
We show here that the conserved E3 ligase Ariadne-1a binds specifically the isoform A of EcR. This interaction results in the quantitative regulation of protein levels of EcRA and its heterodimeric partner, USP, that change in opposite directions. In addition, this E3 enzyme is able to ubiquitylate EcRA in vitro in the presence of its native E2, UbcD10. The levels of ARI-1a also lead to transcriptional changes in several 20E-dependent genes including EcR and usp.
ARI-1a in metamorphosis
The excess as well as the lack-of-function conditions for ARI-1a cause lethality at the same developmental phase, metamorphosis. Since isoform A of EcR is particularly abundant in imaginal tissues, the lethality phase is coherent with the molecular interaction. The fact that metamorphosis is affected by deviations, in either direction, of EcRA and USP protein levels underlies the significance of the proper stoichiometry of these two transcription factors at this stage of development. Previous studies have led to a functional model in which the heterodimer EcR/USP acts as a transcriptional repressor until binding 20E, when additional cofactors would be recruited and the complex will become an activator (Schubiger et al. 2005; Beck et al. 2009 ). In an attempt to summarize the data reported here and merge them with those previously published, we assume that EcRA and USP are in equilibrium between the bound and dissociated states (Fig. 7A) . The ubiquitylation activity of ARI-1a will determine, via proteasome, the levels of EcRA. If EcRA increases, the equilibrium will be displaced to favor the dimerized complexes which will act as transcriptional repressors since ecdysone is not yet present. In addition, to explain the opposite direction of the changes in the protein levels of EcRA and USP, we speculate that the unliganded dimer EcRA/USP could repress each other's gene transcription. As ecdysone titers peak at the onset of metamorphosis, the equilibrium would further displace towards the formation of liganded dimers which should act now as transcriptional activators. In the ari-1a activator/repressor complexes will be altered and, thus, lethality will ensue (Fig. 7B) . Further and focused experiments will determine if this tentative mechanism is indeed correct. This
proposal is a generic model of titration between EcRA and USP, and cellular heterogeneities throughout the body could represent significant functional differences. Nevertheless, the fact that metamorphosis is the lethal phase for both the lack-and the excess of ARI-1a function compels us to give a key role to 20E.
Mechanisms of ARI-1a activity
ARI-1a exhibits two types of regulatory effects on EcRA, at the protein and at the transcription levels. The effects at the protein level can be interpreted as a result of the E3 ubiquitylation activity and degradation through the proteasome pathway. The effects on EcRA transcription may be indirect and result from a feed back transcriptional regulation of EcRA, on its own gene, EcR. This putative feed back mechanism could explain the transcriptional effects of ARI-1a on the other EcR isoforms, B1 and B2 (Fig. 4) . However, although EcR transcription is known to depend on 20E (Karim & Thummel 1992; Varghese & Cohen 2007) , the direct implication of EcRA in a feed back mechanism remains to be demonstrated. The isoform specific regulation of EcR by an E3 enzyme invites to explore if a similar mechanism could regulate other isoforms. Different E3s could exert this regulation on EcRB1 and EcRB2.
This hypothetical regulation would make biological sense in those cells where several EcR isoforms are co-expressed. This is only known to occur in the prothoracic cells of the ring gland, where ecdysone is synthesized. Most other tissues appear to express mainly one isoform (Talbot et al., 1993) . However, we have shown here that the Malpighian tubules express, at least the RNAs for all isoforms (Fig. 5) . Thus, the tissue expression data for this gene and its three isoforms may require revision. Alternatively, ARI-1a could be inhibited in a tissue or cell-specific manner. In any case, the changes in the relative stoichiometry of EcR isoforms is likely to have widespread transcriptional consequences since they are nuclear receptors and they act differently as monomers versus dimerized with USP and 20E bound.
At present, we can not resolve if ARI-1a binds EcRA as a complex with USP or as a monomere. Although speculative at this time, it is conceivable that ARI-1a could elicit cytoplasm-nuclear translocation by means of monoubiquitylation of EcRA where the third element, USP, would join in, and titrate EcRA concentration via proteasome by means of polyubiquitylation. As a precedent, the protein Parkin, a RING finger protein related to ARI1a and a cause of Parkinson's disease, is capable of mono-and polyubiquitylate its substrates (Hampe et al. 2006) . On the other hand, while USP seems to localize within the nucleus only, the presence of EcRA (Gwozdz et al. 2007 ) and ARI-1a (Aguilera et al. 2000) in the cytoplasm makes plausible that their interaction could elicit fast, non-transcriptional, events such as G-protein coupled cellular responses to 20E (Srivastava et al. 2005) . In this report, however, we have dealt with the functional bases of EcRA/ARI-1a interactions only.
These features from Drosophila are likely to be relevant to other species as well, given the conservation of ARI type of E3 enzymes (Marin & Ferrus 2002; Mladek et al. 2003 ) and the EcR type of nuclear receptors (King-Jones & Thummel 2005) . Thus, it will be worth investigating if the human liver X receptor, orthologue of EcR, undergoes a similar regulatory process by the human ARI-1a. Considered in a wider context, the specificity of hormone receptor signaling seems to depend, not only on the particular activated isoform, but also on the isoform specific mechanism of modulation. The data reported here illustrate one such mechanism that yields specific phenotypes and has gene transcriptional effects. In addition, the described process represents a mechanism to co-regulate other functionally linked nuclear receptors, USP in this case. (tubulin-Gal4-LL7>UAS-ari-1a) is lethal, mostly at the white pre-pupae stage (WP). B, Overexpression in the muscles (how-Gal4-24B>UAS-ari-1a) yields cryptocephalic pupae with defective head eversion and compressed thorax at the anterior end of the pupal case (anterior is up). C, Wild type pupae at the same age to serve as a reference. D-J, Wing morphology is affected compared to a wild type (D), when ari-1a is over-expressed using the Gal4 drivers (Ghbeish et al. 2001) , and the allele ari-1a 2 is defective in the binding of the E2 enzyme UbcD10 required for substrate ubiquitylation (Aguilera et al. 2000) . EcRA. Note that in both cases the amount of membranous signal is increased with respect to controls. F and G, By contrast, the under-expression of EcRB1 yields no effect demonstrating that the phenomenon is specific of EcRA. The under-expression of EcRA and EcRB1 was performed by driving the expression of the corresponding RNAi constructs with Gal4-C649. 
